Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "Treatment Of Human Viral Diseases"

This new pill regimen could be very effective at preventing HIV transmission
Business Insider

Novel HIV Vaccine Prevents Disease in Monkeys

US researchers are calling it a "Big Deal." Next year, human clinical trials could begin on a novel AIDS treatment that alters DNA, turning cells into HIV fighters. The treatment has completely protected monkeys from a primate version of the immune ... VOA News, 1 week ago

17 images for Treatment Of Human Viral Diseases

Japan Times, 1 week ago
Drug Discovery and Development, 3 days ago
Discovery Channel, 6 days ago
Bioscience Technology Online, 3 weeks ago, 2 weeks ago
CNN, 4 weeks ago
Cleanroom Technology, 2 weeks ago
Boston Globe, 3 weeks ago
Boston Globe, 3 weeks ago
Slate Magazine, 4 weeks ago

Biota Pharmaceuticals to Acquire Anaconda Pharma

Phase 2 Antiviral for the Treatment of Diseases Caused by Human Papillomavirus Strengthens Pipeline Conference Call Today at 9:00 A.M. EST ATLANTA, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals (Nasdaq:BOTA) (the "Company") ...
 Virtual Strategy Magazine1 week ago Biota Pharmaceuticals to Acquire France's Anaconda Pharma  BusinessWeek6 days ago Biota to Acquire Anaconda Pharma for Up-to-$38M  Genetic Engineering News1 week ago Biota Acquires Anaconda Pharma  Contract Pharma1 week ago

Crohn's Drug Tysabri Shows Promise in Efforts to Combat HIV's 'Viral Reservoirs'

CHESTNUT HILL, Mass . — A drug used to treat patients with Crohn's disease and multiple sclerosis has helped scientists confirm how "viral reservoirs" form in patients living with HIV and also proven effective in animal trials at blocking the ...
 EndoNurse1 week ago MS drug Tysabri shows promise in efforts to combat HIV's 'viral reservoirs'  Medical News Today1 week ago The New Drug Wars  Rand3 days ago

Minipool technology to prepare immunoglobulins to treat primary immunodeficiency and fight viral infections, such as Ebola, in developing countries

Ratings require JavaScript to be enabled. A study publishing in PLOS Neglected Tropical Diseases describes a new, pragmatic, method for the production of immunoglobulin G (IgG) from human plasma in developing countries. IgG are therapeutic ...
 Medical News Today6 days ago

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that it has dosed in New Zealand the first patient in a Phase IIb/III clinical trial of ABX203 which is taking place in ...
 News-Medical.Net1 week ago ABIVAX Recruits First Patient In A Pivotal Phase IIb/III Clinical Trial With ABX203, A Novel Immunotherapy Against Chronic Hepatitis B  TheStreet.com1 week ago
SPi World News

Biota Commences Dosing in Vapendavir SPIRITUS Phase 2b Trial

"There are no antivirals currently approved for the treatment of HRV infection, which is a major cause of disease exacerbation among patients with asthma and COPD. Therefore, the initiation of this important trial of vapendavir in moderate-to-severe ...
 Morningstar.com2 days ago Biota Pharmaceuticals to buy Anaconda Pharma, Paris, France  Individual.com6 days ago Biota begins patient dosing in phase 2b SPIRITUS trial of vapendavir  PharmaBiz13 hours ago Biota Pharmaceuticals, Inc. To Present At The 27th Annual Conference  BioSpace1 day ago

Orphan designation: Adeno-associated viral vector serotype rh.rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA, for the: Treatment of mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)

orphan designation (EU/3/14/1389) was granted by the European Commission to Lysogene, France, for adeno-associated viral vector serotype rh.rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA for the treatment of mucopolysaccharidosis ...
 European Medicines Agency1 week ago

Rutgers Grant Results in HIV Testing for Newark University Hospital Emergency Patients

Of the estimated 1.2 million Americans living with Human Immunodeficiency Virus (HIV), one in seven are unaware that they are infected. Rutgers New Jersey Medical School believes routine screening for HIV can significantly reduce that number in the ...
 Noodls1 week ago Immune Biomarkers Predict Early Death in HIV Patients with TB  Lab Medica1 week ago

Ebola Drug Shows Signs of Efficacy Among Early Patients in Study

(Bloomberg) -- An experimental Ebola treatment may have helped some patients survive when used at the early stages of disease in West Africa, researchers said. Among 80 patients who got the antiviral drug favipiravir, the death rate for those ...
 Bloomberg1 week ago

Cocrystal Pharma to Present at Barclays Global Healthcare Conference on Thursday, March 12

) - Cocrystal Pharma, Inc. ( OTCQB: COCP ), a company focused on developing novel antiviral therapeutics for human diseases, announced today that it will present at the Barclays 2015 Global Healthcare Conference on Thursday, March 12, 2015 at 8:00 ...
 Minyanville2 days ago Opko Health : Cocrystal Pharma to Present at Barclays Global Healthcare Conference on Thursday, March 12  4 Traders2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment Of Human Viral Diseases
Get updated on latest news & your favorite topics right in your inbox!
More     Less